Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Landsem

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Thrombosis Research|May 20, 2016
C1-inhibitor efficiently delays clot development in normal human whole blood and inhibits Escherichia coli-induced coagulation measured by thromboelastometryA Landsem, H Fure, T E Mollnes, et al.
Clinical and Experimental Immunology|August 5, 2015
The key roles of complement and tissue factor in Escherichia coli-induced coagulation in human whole bloodA Landsem, H Fure, D Christiansen, et al.
Molecular Immunology|May 19, 2019
Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14E W Skjeflo, D Christiansen, A Landsem, et al.
Clinical and Experimental Immunology|April 24, 2013
C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole bloodA Landsem, E W Nielsen, H Fure, et al.
Clinical and Experimental Immunology|November 19, 2016
Systemic inflammation in acute intermittent porphyria: a case-control studyE Storjord, J A Dahl, A Landsem, et al.
Clinical and Experimental Immunology|November 17, 2018
Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4A Landsem, H Fure, J Krey Ludviksen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Thrombosis Research|May 20, 2016
C1-inhibitor efficiently delays clot development in normal human whole blood and inhibits Escherichia coli-induced coagulation measured by thromboelastometryA Landsem, H Fure, T E Mollnes, et al.
Clinical and Experimental Immunology|August 5, 2015
The key roles of complement and tissue factor in Escherichia coli-induced coagulation in human whole bloodA Landsem, H Fure, D Christiansen, et al.
Molecular Immunology|May 19, 2019
Phagocytosis of live and dead Escherichia coli and Staphylococcus aureus in human whole blood is markedly reduced by combined inhibition of C5aR1 and CD14E W Skjeflo, D Christiansen, A Landsem, et al.
Clinical and Experimental Immunology|April 24, 2013
C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole bloodA Landsem, E W Nielsen, H Fure, et al.
Clinical and Experimental Immunology|November 19, 2016
Systemic inflammation in acute intermittent porphyria: a case-control studyE Storjord, J A Dahl, A Landsem, et al.
Clinical and Experimental Immunology|November 17, 2018
Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4A Landsem, H Fure, J Krey Ludviksen, et al.
Pageof 1